BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

133 related articles for article (PubMed ID: 37634608)

  • 1. Hyperspectral imaging to predict the effect of cyclophosphamide in primary membranous nephropathy.
    Liu W; Hou X; Li Y; Wang Z
    Photodiagnosis Photodyn Ther; 2023 Dec; 44():103751. PubMed ID: 37634608
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Clinicopathological features and outcome in elderly patients with idiopathic membranous nephropathy.
    Liang J; Hao W; Xia F; Zhao Z; Wu Y; Yu F; Hu W; Fang X; Liu W
    Ren Fail; 2023 Dec; 45(1):2212081. PubMed ID: 37194712
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Short- and long-term efficacy of oral cyclophosphamide and steroids in patients with membranous nephropathy and renal insufficiency. Study Group.
    Branten AJ; Wetzels JF
    Clin Nephrol; 2001 Jul; 56(1):1-9. PubMed ID: 11499653
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Efficacy and safety of tacrolimus vs cyclophosphamide in the therapy of patients with idiopathic membranous nephropathy: a meta-analysis.
    Lin W; Li HY; Lin S; Zhou T
    Drug Des Devel Ther; 2019; 13():2179-2186. PubMed ID: 31308629
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Efficacy of leflunomide combined with prednisone for the treatment of PLA2R-associated primary membranous nephropathy.
    Guo Y; Wu X; Liu L; Zhang H; Yang L; Chen W
    Ren Fail; 2020 Nov; 42(1):122-130. PubMed ID: 31957527
    [No Abstract]   [Full Text] [Related]  

  • 6. Substitution of Oral for Intravenous Cyclophosphamide in Membranous Nephropathy.
    Luzardo L; Ottati G; Cabrera J; Trujillo H; Garau M; González Bedat C; Coitiño R; Aunchayna MH; Santiago J; Baldovinos G; Silvariño R; Ferreiro A; González-Martínez F; Gadola L; Noboa O; Caorsi H
    Kidney360; 2020 Sep; 1(9):943-949. PubMed ID: 35369556
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Efficacy and Safety of Tacrolimus Versus Cyclophosphamide for Primary Membranous Nephropathy: A Meta-Analysis.
    Zhu LB; Liu LL; Yao L; Wang LN
    Drugs; 2017 Feb; 77(2):187-199. PubMed ID: 28084563
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Intravenous pulse cyclophosphamide and steroids induce immunological and clinical remission in New-incident and relapsing primary membranous nephropathy.
    Kanigicherla DAK; Hamilton P; Czapla K; Brenchley PE
    Nephrology (Carlton); 2018 Jan; 23(1):60-68. PubMed ID: 27778424
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [The clinical efficacy and safety of modified Ponticelli regimen for treatment of idiopathic membranous nephropathy].
    Xia W; Pei H; Li S; Fu S; Tian L
    Zhonghua Nei Ke Za Zhi; 2016 Mar; 55(3):181-5. PubMed ID: 26926368
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Phospholipase-A2 receptor antibody, 24 hours proteinuria, and serum albumin as indicators of cyclophosphamide efficacy in idiopathic membranous nephropathy.
    Xiao C; Liu Y; Zhang X; Luo L; Li X; Wang T; Tian Z; Qin X; Liu J
    J Clin Lab Anal; 2020 Sep; 34(9):e23368. PubMed ID: 32449206
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Corticosteroids, cyclophosphamide, and chlorambucil therapy of membranous nephropathy.
    Passerini P; Ponticelli C
    Semin Nephrol; 2003 Jul; 23(4):355-61. PubMed ID: 12923723
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [A novel approach to rapid induction of remission in primary membranous nephropathy].
    Dobronravov VA; Bystrova OB; Kochoyan ZS; Fomicheva EN
    Ter Arkh; 2021 Jun; 93(6):706-712. PubMed ID: 36286838
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Effectiveness and safety of cyclophosphamide or tacrolimus therapy for idiopathic membranous nephropathy.
    Zou H; Jiang F; Xu G
    Ren Fail; 2019 Nov; 41(1):673-681. PubMed ID: 31354007
    [No Abstract]   [Full Text] [Related]  

  • 14. Synthetic ACTH in High Risk Patients with Idiopathic Membranous Nephropathy: A Prospective, Open Label Cohort Study.
    van de Logt AE; Beerenhout CH; Brink HS; van de Kerkhof JJ; Wetzels JF; Hofstra JM
    PLoS One; 2015; 10(11):e0142033. PubMed ID: 26562836
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Combination therapy with rituximab, low-dose cyclophosphamide, and prednisone for idiopathic membranous nephropathy: a case series.
    Cortazar FB; Leaf DE; Owens CT; Laliberte K; Pendergraft WF; Niles JL
    BMC Nephrol; 2017 Feb; 18(1):44. PubMed ID: 28143416
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of a second course of immunosuppressive therapy in patients with membranous nephropathy and persistent or relapsing disease activity.
    du Buf-Vereijken PW; Wetzels JF
    Nephrol Dial Transplant; 2004 Aug; 19(8):2036-43. PubMed ID: 15187191
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Outcome of Idiopathic Membranous Nephropathy: A Retrospective Study.
    Rozenberg I; Kotliroff A; Zahavi T; Benchetrit S
    Isr Med Assoc J; 2018 Mar; 20(3):186-189. PubMed ID: 29527859
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Risk of infection with different immunosuppressive drugs combined with glucocorticoids for the treatment of idiopathic membranous nephropathy: A pairwise and network meta-analysis.
    Liu D; Yang Y; Kuang F; Qing S; Hu B; Yu X
    Int Immunopharmacol; 2019 May; 70():354-361. PubMed ID: 30852290
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Immunosuppressive Treatments for Idiopathic Membranous Nephropathy: A Pilot Study According to Histopathological Stages.
    Yan Z; Hu L; Xu G
    Am J Med Sci; 2022 May; 363(5):444-451. PubMed ID: 34606753
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Hyperspectral imaging-based cutaneous wound classification using neighbourhood extraction 3D convolutional neural network.
    Cihan M; Ceylan M
    Biomed Tech (Berl); 2023 Aug; 68(4):427-435. PubMed ID: 36862718
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.